Syncope during boceprevir treatment in hepatitis C

Ann Hepatol. 2013 Sep-Oct;12(5):837-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Proline / adverse effects
  • Proline / analogs & derivatives*
  • Risk Factors
  • Severity of Illness Index
  • Syncope / chemically induced*
  • Syncope / diagnosis

Substances

  • Antiviral Agents
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline